NRx - About the company
NRx is a public company based in Wilmington (United States), founded in 2017 by Daniel C Javitt. It operates as a Developer of therapeutics for COVID-19 and neurological disorders. NRx has raised an undisclosed amount in funding.
Company Details
Developer of therapeutics for COVID-19 and neurological disorders. The company's product include ZYESAMI contains aviptadil acetate for COVID-19 with respiratory failure, NRX-101, and NRX-100 for the treatment of acute suicidal behavior in bipolar disorder.
- Website
- www.nrxpharma.com/
- Email ID
- *****@nrxpharma.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2017
Location
Wilmington, United States
Stage
Public
Latest Funding Round
Investors
Ranked
1st among 1 active competitor
Employee Count
18 as on Aug 31, 2026
Exit Details
Public
Legal entities associated with NRx
NRx is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
NRX PHARMACEUTICALS, INC. CIN: 1719406 , United States, Active | Sep 17, 2017 | - | 1 (As on May 31, 2022) | - |
NRx Pharmaceuticals, Inc CIN: -1719406 , United States, Active | Sep 17, 2017 | - | - | - |
NRx's IPO details
NRx got listed on Nov 20, 2017.
Click here to take a look at NRx's IPO in detail
Sign up to download NRx's company profile
NRx's funding and investors
NRx has raised funding over 3 rounds. Its first funding round was on Feb 01, 2017. NRx has 3 institutional investors.
Here is the list of recent funding rounds of NRx:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 02, 2022 | 9509877 | Post IPO | 8306662 | 2080949 | 7968992 | 5171804 |
Aug 19, 2021 | 3680511 | Post IPO | 9936379 | 1481400 | 1423975 | 3862495 |
Feb 01, 2017 | 3095864 | Grant (prize money) | 6736624 | 2429091 | 8732951 |
View details of NRx's funding rounds and investors
NRx's founders and board of directors
Founder? Claim ProfileThe founders of NRx is Daniel C Javitt.
Here are the details of NRx's key team members:
- Daniel C Javitt: Co-Founder of NRx. Contact Info: 1 email address
View details of NRx's Founder profiles and Board Members
NRx's employee count trend
NRx has 18 employees as of Aug 26. Here is NRx's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
NRx's Investments and acquisitions
NRx has made no investments or acquisitions yet.
Reports related to NRx
Here is the latest report on NRx's sector:
News related to NRx
Media has covered NRx for a total of 27 events in the last 1 year, 9 of them have been about company updates and 1 about partnerships.
•
•
NRx Pharmaceuticals GAAP EPS of -$0.44, revenue of $1.1M (NRXP:NASDAQ)Seeking Alpha•Aug 17, 2026•NRx
•
•
Certain Common Stock of NRx Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 3-AUG-2026.Stock Screener•Aug 03, 2026•NRx
•
NRx Pharmaceuticals Responds to Kadima Dispute and Affirms Strategic DirectionGlobeNewswire•Jun 26, 2026•NRx
•
NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for NRX-101 for Depression TreatmentGlobeNewswire•Jun 22, 2026•NRx
•
•
NRx Pharmaceuticals Closes $22.3 Million Public Offering of Common StockGlobeNewswire•Jun 04, 2026•NRx
•
NRx Pharmaceuticals Announces Proposed Public Offering of Common StockGlobeNewswire•Jun 02, 2026•NRx
•
NRx Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate UpdateGlobeNewswire•May 18, 2026•NRx
Are you a Founder ?
FAQs about NRx
Explore our recently published companies
- Riverside Marketing - United Kingdom based, 2020 founded, Unfunded company
- CTEBBUTT - London based, Unfunded company
- Bankeronwheels - 2020 founded, Unfunded company
- April Bakery - Thailand based, 2010 founded, Unfunded company
- The Bailey Team - Whitefish Bay based, Unfunded company
- OpenGenX - Madurai based, 2025 founded, Unfunded company